Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

Prolactin may play a significant role in skin and hair health and could be a target for treating skin and hair disorders.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Fibroblasts, cells usually linked to tissue repair, also help regenerate various organs and their ability decreases with age. Turning adult fibroblasts back to a younger state could be a new treatment approach.

Acanthosis nigricans is a skin condition that may indicate a higher risk for insulin resistance and type 2 diabetes, and more research is needed to understand and treat it.

Activating NRF2 might help treat hair disorders by improving antioxidant defenses.

Women with high androgen levels may have more severe COVID-19 symptoms.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Platelet-Rich Plasma (PRP) is a low-risk treatment for Androgenic Alopecia (AGA) that generally improves hair count or density, but more research is needed for optimization.

Taking tamsulosin or finasteride and being older increase the risk of floppy iris during cataract surgery.

Overweight smokers have worse hair loss.

The study concludes that mutations in the AEBP1 gene can cause a form of Ehlers-Danlos syndrome and should be considered in diagnosis.

The study concluded that hair loss in Indian women is not significantly linked to anemia or thyroid problems, but checking thyroid function could help those with ongoing hair loss.

Caregiver burden and patient health issues significantly affect emotional distress in both COPD patients and their caregivers.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

Early hair whitening may indicate a higher risk of heart disease in young and middle-aged men.

The document concludes that while "hair follicle cloning" shows promise for unlimited donor hair, it faces challenges with consistency and safety in humans.

Hair loss links to high blood pressure, high fat levels, and metabolic issues, suggesting early heart disease screening.

Treat limited stage small cell lung cancer with chemotherapy and radiation, and consider preventive brain radiation for better survival chances.

Hair characteristics might be early signs of Type 2 Diabetes and could help with early prevention.

Changes in testosterone and estrogen receptor genes can affect how men age, influencing body fat, hair patterns, and possibly leading to skin disorders.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

The study found that the cause of alopecia areata can be identified through tissue analysis, and vertical sections are enough for diagnosis.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Most hospitalized internal medicine patients have undiagnosed skin problems and want them treated.

Machine learning can accurately diagnose PCOS non-invasively using clinical and ultrasound features.

Polycomb Repressive Complex 2 is not needed for hair regeneration.

Most people in Turkey start getting gray hair around 33 years old, with factors like age, education, hair loss, skin type, family history, and anxiety playing a role.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.